Biotechnology - Research and Markets - RSS Feed

Beneluxian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009

press@researchandmarkets.com — Thu, 19 Nov 2009 14:23:59 GMT

The Beneluxian market for dental bone graft substitutes and other biomaterials, which includes Belgium, the Netherlands and Luxemburg, was the seventh largest in Europe in 2008 The Netherlands represented the vast majority of this market, which grew significantly in 2007 The rapid growth in the...

Marine Biotechnology - Worldwide Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:58 GMT

Comprising the largest part of the planet's biosphere, the marine environment contains the most diverse and ancient forms of life. The advent of advanced scientific disciplines such as molecular biology, genomics, bioinformatics and application of information technology to biotechnology, has tremendously enhanced human understanding of marine life. Widening applications in several end-use areas including marine transportation, environmental remediation, cosmetics, research, and food sectors also contributed to market growth. However, the industry is still in a nascent stage and is a significantly small part of the overall biotech market.

These and other market data and trends are presented in "Marine Biotechnology: Worldwide Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

Genetic Testing - A Global Update of Market Trends & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:56 GMT

Genetic testing, which of-late has been transforming itself from service driven to product-driven market is expected to provide an impetus to diagnostic companies with respect to expansion of their operations. Genetic testing market has been witnessing a rise in demand from various quarters, which include medical, paternity & forensics departments, immigration & insurance sectors and DNA banks. Increasing emphasis on the need to develop new and more effective testing methods is projected to further propel the market growth. The early detection of genetic disorders using genetic testing would significantly reduce morbidity as well mortality rates.

These and other market data and trends are presented in "Genetic Testing: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Collagen and HA-based Biomaterials - Global Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:55 GMT

Biomaterials are considered one of the most exciting areas for medical devices. The future holds immense potential in terms of developing new products with wide application range. Technological breakthroughs in fields such as "dermal implants" will lead to preference/choice of treatment in future. Growth in the biomaterials market continues to be fueled by heightened interest in personal healthcare, strong demographic shifts of aging population coupled with technological and process breakthroughs.

These and other market data and trends are presented in "Collagen and Ha-based Biomaterials: Global Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Gene Therapy - Worldwide Market Challenges & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:54 GMT

Gene therapy promises to be one of the most important frontiers in medicine. Although no significant achievements for curing disease have been achieved, the future seems to hold significant potential in terms of developing such approaches. Advancements in gene therapy have provided useful data, which has helped in understanding the pathogenesis of diseases. The discipline heralds a significant potential for the biotechnology industry over the very long term, as the approach moves from research labs to clinical trials. Proteins and monoclonal antibodies have revolutionized the treatment of a wide variety of diseases, and gene-based therapies that deliver the DNA sequences encoding proteins and antibodies signify the next big step in the evolution of biopharmaceuticals. Gene therapy market is still in the experimental stages with success yet to be achieved in developing completely curative therapeutic drugs.

These and other market data and trends are presented in "Gene Therapy: Worldwide Market Challenges & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Gene Amplification Technologies - Trends & Opportunities Worldwide

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:53 GMT

Molecular diagnostics and the Human Genome Project have been the major growth drivers for gene amplification technology. Amplification is a mechanism by which cells are amplified or synthesized from a single copy of gene. Gene amplification technology addresses applications in molecular biology research (DNA amplification), gene therapy, drug discovery, forensic identification, and diagnosis.

Gene amplification technology plays a vital role in the diagnostics field. With increasing aging population, countries worldwide face the challenge of preventing age-related diseases such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics including genetic testing which make use of gene amplification technology. With growing improvements in the diagnostic market, the DNA diagnostic technologies are set to achieve superior efficiencies and improved activity in numerous application areas, including healthcare, biomedical research, toxicology, bioremediation, forensics and personnel identification, environmental monitoring, quality control in the food industry, and agriculture.

These and other market data and trends are presented in "Gene Amplification Technologies: Trends & Opportunities Worldwide" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Biocompatible Materials - A Global Market Trajectory

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:52 GMT

Rapid development of tissue engineering as a prime technology in research sciences is largely anticipated to shape the future of biocompatible materials. Other factors to reckon with include advancements in fundamental understanding of biocompatibility science, expanding arena of coating technology, and the development of novel synthetic materials for medical applications. Nanotechnology is also used for creating very small, compact biomaterial devices including drug delivery vehicles and medical implants. Biocompatible materials are fast turning out to be a challenging area of research in the biosciences field. Several innovative products such as total artificial heart system, pneumatic total artificial heart, artificial blood vessels, and artificial blood among others are being developed that can be effectively used as substitutes for human body parts.

These and other market data and trends are presented in "Biocompatible Materials: A Global Market Trajectory" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Automated and Rapid Microbiological Tests - A Worldwide Market Review

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:52 GMT

High prevalence of infectious diseases and sexually transmitted diseases (STDs) continue to drive the automated and rapid tests market, as need for quicker, higher volume and more accurate methods of testing gains importance. With humans and bacteria locked in a perennial biological warfare, there exists a perpetual need for new and advanced rapid microbial testing methods and instruments. Hitherto growth in the automated microbiological test systems market stemmed from laboratories worldwide embarking on the transition from manual to automated forms of testing.

Technology developments and changes have initiated sweeping changes in the market for automated and rapid microbiological tests. With probe tests threatening the survival of immunoassay based rapid tests and with advances in automated microbiological testing systems promising potential opportunities, the landscape is fraught with a unique mixture of opportunities and related threats. The new methods offer greater speed, accuracy, specificity and sensitivity than can be achieved with conventional culturing or immunoassay methods. Molecular diagnostics is the new enabling technology of numerous next generation rapid microbiology test kits.

These and other market data and trends are presented in “Automated and Rapid Microbiological Tests: A Worldwide Market Review” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Agricultural Biotechnology - Global Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:52 GMT

Biotechnology is considered to be the most promising technology that can provide lasting solution to various problems ranging from food shortage to preservation of environmental resources. Much of the interest in biotechnology stems from rapid dissemination in North America and other exporting countries of genetically engineered (GE) crops such as soybeans, cotton, canola, and corn. In agricultural biotechnology, wide array of transgenic crops integrate genetically altered and enhanced attributes that assist plants to build resistance against particular pests and herbicides.

These and other market data and trends are presented in “Agricultural Biotechnology: Global Market Trends” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Probiotics - A Global Update of Market Trends & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:52 GMT

Probiotics are considered to be the vital healthcare concept of the 21st century. As people become increasingly health conscious, preventive medicine in the form of probiotic foods is gaining popularity. While already widely known and put to extensive use by Asians and Europeans, the trend for probiotics is catching up with the world populace. Probiotics is witnessing extensive scientific research work as new probiotic strains and new applications are under development. Apart from gastrointestinal problems, new target areas for probiotics include inflammatory diseases, allergy prevention, cholesterol reduction and prevention of colon cancer.

The issue of genetically modified cultures, however, threatens the market. To counter this problem, many marketers are promoting their products to be free from genetically modified organisms (GMOs). Some supplement companies in order to increase their market share are making health claims that are misleading and lack scientific evidence. This may influence the market negatively, as consumer confidence in probiotics products gets tampered and it requires high marketing efforts to get them back to the market.

These and other market data and trends are presented in “Probiotics: A Global Update of Market Trends & Opportunities” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Biometrics - Trends & Opportunities Worldwide

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:51 GMT

Increasing security concerns ranging from individual identity theft, corporate security, to even national security represents factors that are important to the biometrics market. Some countries have already rolled out biometric systems at airports and other ports of entry to check flow of illegal immigrants into their respective territories. On the technological front, non-contact systems could emerge as the answer to expel inhibitions exhibited by users. Development of industry-wide standards has been initiated by some industry groups, which would lead to lower costs and enable easier adoption of present and emerging technologies. Government initiatives could emerge as the key to biometrics growth.

These and other market data and trends are presented in “Biometrics: Trends & Opportunities Worldwide” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Biochips - A Global Update of Market Trends & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:51 GMT

Significant dimensions of the vast parallel studies afforded by biochips have created a holistic means of viewing biological systems. In addition to the combination of various sciences, space, time and expense are all key factors in the future development of biochips. Modern day chips can contain a human genome comprising of 30,000 to 100,000 genes.

The biochip industry is in the early stages of growth and hence, not only promises potential but also is susceptible to vagaries of market forces. Competition, patent disputes, knowledge constraints (in terms of skilled employees, technical know-how) and financial strength might be a few impediments for firms engaged in this industry. A promising market arises from three factors - an aging population, third party reimbursement and a growing number of individuals suffering from common chronic diseases. Biochips would certainly evolve in terms of physical, technical characteristics, and with focus on miniaturization of assays, they would turn smaller and more powerful with each generation. The industry is characterized by both intense rivalry and equally well-developed web of alliances.

These and other market data and trends are presented in “Biochips: A Global Update of Market Trends & Opportunities” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Signal Crosstalk in Plant Stress Responses

press@researchandmarkets.com — Tue, 17 Nov 2009 10:20:05 GMT

Signal Crosstalk in Plant Stress Responses summarizes the current body of knowledge on crosstalk between plant stresses, providing a further understanding of the complexity of signal crosstalk Since plants are continually exposed to multiple stresses, the signal transduction pathways must...

Success Rates in Biotech - Going The Wrong Way

press@researchandmarkets.com — Mon, 16 Nov 2009 11:50:35 GMT

The report "Success Rates in Biotech - Going The Wrong Way" summarises our review of 211 public biotech companies comprising over 1,500 drug development projects We have studied the clinical pipelines going back to 2002 based on financial reports and found a striking difference of success...

Developing Managed Care Pull-Through Excellence

press@researchandmarkets.com — Mon, 16 Nov 2009 09:26:25 GMT

In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies but also to ""pull through"" the business and increase market share after a win To benefit from formulary wins, savvy companies ensure that their sales forces and account...

Managed Markets Account Management: Assessing the Performance of Account Executives

press@researchandmarkets.com — Mon, 16 Nov 2009 09:14:53 GMT

This study was conducted to identify common performance measurement practices across geographies and hierarchy, provide insight into effective evaluation of the function and determine measures that drive functional success Today's market driven environment has made performance assessment of managed...

Best Practices for Post-Marketing Surveillance of Adverse Events within the U.S.

press@researchandmarkets.com — Fri, 13 Nov 2009 16:00:09 GMT

Medical and scientific progress has been enormous in the past decades However, this has also raised several safety issues leading to increased vigilance on bio-pharma companies by the U S Food and Drug Administration Authority Under such circumstances, it is imperative for the bio-pharmaceutical...

Best Practices for Internal Communications Regarding Brands & Disease States

press@researchandmarkets.com — Fri, 13 Nov 2009 15:45:39 GMT

This benchmarking study, based on benchmark survey data and executive interviews of 45 participants from more than 34 leading pharmaceutical, biotechnology and medical device companies, was conducted to examines the programs and initiatives aimed at directly affecting the lives and treatment of...

2009 Plimsoll Analysis - Bioscience - A comprehensive profile of 186 companies operating in the UK market

press@researchandmarkets.com — Wed, 11 Nov 2009 15:34:45 GMT

The UK Bioscience market analysis This edition of the Plimsoll Analysis is the most comprehensive review yet of the UK Bioscience industry With the market due for a prolonged period of consolidation to weed out over capacity and weakened competitors, keeping up with development will be vitally...

Pharmaceutical Industry in South Africa

press@researchandmarkets.com — Tue, 03 Nov 2009 10:10:41 GMT

The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late 19th century The invention of penicillin can yet be recognized as a major...

Pharmaceutical Industry in Czech Republic

press@researchandmarkets.com — Tue, 03 Nov 2009 10:08:44 GMT

Pharmaceutical Industry in Russia

press@researchandmarkets.com — Tue, 03 Nov 2009 10:06:54 GMT

Pharmaceutical Industry in Germany

press@researchandmarkets.com — Tue, 03 Nov 2009 10:05:09 GMT

Pharmaceutical Industry in Belgium

press@researchandmarkets.com — Tue, 03 Nov 2009 10:03:22 GMT

Pharmaceutical Industry in Hungary

press@researchandmarkets.com — Tue, 03 Nov 2009 10:01:30 GMT

Pharmaceutical Industry in Taiwan

press@researchandmarkets.com — Tue, 03 Nov 2009 09:59:30 GMT

Pharmaceutical Industry in Norway

press@researchandmarkets.com — Tue, 03 Nov 2009 09:57:32 GMT

Pharmaceutical Industry in Brazil

press@researchandmarkets.com — Tue, 03 Nov 2009 09:55:21 GMT

Pharmaceutical Industry in the Netherlands

press@researchandmarkets.com — Tue, 03 Nov 2009 09:38:27 GMT

Pharmaceutical Industry in Italy

press@researchandmarkets.com — Tue, 03 Nov 2009 09:36:17 GMT

Pharmaceutical Industry in South Korea

press@researchandmarkets.com — Tue, 03 Nov 2009 09:34:03 GMT

Pharmaceutical Industry in Spain

press@researchandmarkets.com — Tue, 03 Nov 2009 09:29:32 GMT

Pharmaceutical Industry in Japan

press@researchandmarkets.com — Tue, 03 Nov 2009 09:27:29 GMT

Pharmaceutical Industry in Sweden

press@researchandmarkets.com — Tue, 03 Nov 2009 09:25:33 GMT

Pharmaceutical Industry in Denmark

press@researchandmarkets.com — Tue, 03 Nov 2009 09:23:22 GMT

Pharmaceutical Industry in Poland

press@researchandmarkets.com — Tue, 03 Nov 2009 09:21:21 GMT

Future of Green Biotechnology in China

press@researchandmarkets.com — Mon, 02 Nov 2009 11:12:50 GMT

This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this field The first edition of this report is finished soon in October 2009 Green biotechnology (GB) is mainly based on...

Genetic Engineering - Global Outlook

press@researchandmarkets.com — Mon, 02 Nov 2009 08:53:32 GMT

The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird’s eye view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry’s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. The report also provides select data on regional markets. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 169 companies active in the market.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Cord Blood Stem Cells - A Global Market Overview

press@researchandmarkets.com — Thu, 29 Oct 2009 09:51:42 GMT

Umbilical cord and placenta, once considered medical waste are emerged to be a valuable source of stem cells The cord blood stem cells show the potential to treat the fatal diseases such as leukemia, cardiac attacks and debilitating diseases including Alzheimer’s and Parkinson’s Cord blood stem...

The Market Outlook for Research Products in FY2010

press@researchandmarkets.com — Thu, 29 Oct 2009 09:18:26 GMT

Money is starting to flow The 8 2 billion dollars appropriated to the NIH Scientific Research program by the American Recovery and Reinvestment Act is being earmarked for lab renovations, Challenge Grants, the Shared Instrumentation Program and research that spans multiple public and non-profit...

Global Top 10 Biotechnology Companies — Industry, Financial and SWOT Analysis

press@researchandmarkets.com — Tue, 27 Oct 2009 12:32:44 GMT

Scope:

‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.

The report includes the following:

- Industry analysis including market value, market volume, market share and forecast growth till 2012
- Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
- SWOT and 5-year financial analysis of top 10 players in the industry
- Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months

The top 10 companies have been ascertained based on their global revenues for the financial year 2008.

Highlights:

The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007-12, which is expected to drive the market to a value of $275.8 billion by the end of 2012.

The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.

The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.

Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.

Reasons to

Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)

press@researchandmarkets.com — Tue, 27 Oct 2009 12:32:11 GMT

The life sciences industry is unique and complex. Without having the proper background, it can be difficult for IT vendors to enter this conservative market. Those willing to put in the extra effort to truly understand the pharmaceutical and biotechnology industries will realize there is considerable opportunity for technology.

Scope

- Offers an overview of the pharmaceutical and biotechnology industries

- Discusses key areas where technology would be most beneficial in the life sciences industry

- Provides go-to-market strategies to help penetrate the pharma and biotech markets

Highlights of this title

On average, it takes about 10-12 years and $1 billion to bring a new drug to market. With a patent life of only 20 years, this does not leave a long market exclusivity period in which to recoup the development costs. Therefore, executives are beginning to look at various technology solutions to lower costs and reduce time-to-market.

Companies are shifting away from the 'one-size-fits-all' blockbuster drug business model. As pressures grow to fill their dwindling product pipeline with innovative drugs, companies are embracing biotechnology and personalized medicine. This has led to a greater demand forthe IT sector to provide the industry with the tools it requires to succeed.

In the past, pharma companies have built their own solutions as they required customized solutions, resulting in an industry plagued with home-grown legacy systems that are difficult to maintain and integrate. IT executives are now beginning to understand the benefits of commercial solutions, but still need time, education and convincing.

Key reasons to purchase this title

- Understand the pharmaceutical and biotechnology product lifecycle

- Identify emerging areas of concern for pharmaceutical and biotechnology companies

- Gain insight into what solutions and services that will appeal most to life sciences companies

2009 CRO Quality Benchmarking Study - CRO Selection for Biotechnology Companies

press@researchandmarkets.com — Thu, 22 Oct 2009 13:51:53 GMT

This is a substantial study based on interviews with 44 biotechnology company representatives, rating 130 unique projects with CROs Respondents graded 10 prominent service providers across 18 important capabilities that affect provider selection and delivery quality The report contains 139 pages,...

Capitalizing on Opportunities in Cord Blood Industry Growth

press@researchandmarkets.com — Wed, 21 Oct 2009 14:12:21 GMT

Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry as well as revenue growth at existing operations Deeper analysis reveals that of existing cord blood banks, most fall into one of two “camps,”...

China: A New Era of Innovation in Drug Development

press@researchandmarkets.com — Mon, 19 Oct 2009 11:12:03 GMT

In the latest edition from our Clinical Trials Special Report Series, we break down China’s clinical trials landscape and analyze the government investments that are making the country more attractive for inclusion in global drug development programs of pharma companies of all sizes Key Features...

European Lab-on-chip and Microfluidics Markets

press@researchandmarkets.com — Thu, 08 Oct 2009 08:36:33 GMT

This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015...

2009 Chemicals, Pharmaceuticals, Medical Products & Biotechnology - UK Key Corporate Changes

press@researchandmarkets.com — Tue, 06 Oct 2009 08:12:51 GMT

The Mandis 2009 Key Corporate Changes report for the UK Chemicals, Pharmaceuticals, Medical Products & Biotechnology Sector will put you ahead of your competition in terms of market knowledge This is an in depth report detailing 304 key changes and developments, covering 196 different companies...

Clinical Bacteriology

press@researchandmarkets.com — Mon, 28 Sep 2009 13:19:03 GMT

In this concise, beautifully illustrated book, the authors introduce the reader to the basic science of medical bacteriology and relate this to clinical practice. By integrating the text with over 270 full-colour diagrams and selected photomicrographs, the book explains the essentials of bacterial infection, and it also provides the basis for logical diagnostic and management strategies, including the use of antibiotics.

Following introductory chapters on the nature, structure and function of bacteria, diagnostic methods and antibiotic use, the principles are then applied to each organ system. Here relevant aspects of epidemiology, pathogenesis, diagnosis, treatment and public health are covered. There are chapters on infection is a modern society, including the immuncompromised patient, and infection control in the hospital and community.

In the context of new problem-based curricula, this book will be welcomed especially by medical students, trainee physicians and microbiologists, laboratory biomedical scientists and nurses working in infection control.

Key features:

- Provides basic understanding of antibiotics and bacterial infection
- Integrates concise text and full-colour diagrams to relate science to clinical practice

Fluorescence Applications in Biotechnology and Life Sciences

press@researchandmarkets.com — Mon, 28 Sep 2009 11:02:21 GMT

A self-contained treatment of the latest fluorescence applications in biotechnology and the life sciences This book focuses specifically on the present applications of fluorescence in molecular and cellular dynamics, biological/medical imaging, proteomics, genomics, and flow cytometry It raises...

Modern Biotechnology : Connecting Innovations in Microbiology and Biochemistry to Engineering Fundamentals

press@researchandmarkets.com — Thu, 24 Sep 2009 15:26:54 GMT

A unique resource for the next generation of biotech innovators Enabling everything from the deciphering of the human genome to environmentally friendly biofuels to lifesaving new pharmaceuticals, biotechnology has blossomed as an area of discovery and opportunity Modern Biotechnology provides a...

Biosimilars (2009 - 2014)

press@researchandmarkets.com — Thu, 24 Sep 2009 14:46:57 GMT

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market The global biosimilars market is expected to be worth US$19 4...

Russia Biofuels Market Potential

press@researchandmarkets.com — Mon, 21 Sep 2009 16:53:53 GMT

Biofuel is any fuel that is derived from biomass - recently living organisms or their metabolic byproducts, such as manure from cows It is a renewable energy source, unlike other natural resources such as petroleum, coal, and nuclear fuels Ethanol is manufactured from microbial conversion of biomass...

Who Cloned My Cat?: Fun Adventures in Biotechnology

press@researchandmarkets.com — Mon, 21 Sep 2009 11:17:12 GMT

"Science is fun!" Is the motto of this fun-filled book by Prof Reinhard Renneberg Do you know that in Japan, washing machines have no "cooking program" thanks to enzyme detergents? How to make German-style beer from rice? How do you make real snow with dead frost-bacteria? Is using bio-ethanol as a...

Nanotherapeutics: Drug Delivery Concepts in Nanoscience

press@researchandmarkets.com — Mon, 21 Sep 2009 10:51:17 GMT

An important and exciting aspect in the newly developing field of nanomedicine is the use of nanoparticle drug delivery systems allowing for innovative therapeutic approaches Due to their small size, these drug delivery systems are promising tools in therapeutic approaches such as selective or...

Carbon Nanotubes: Angels or Demons?

press@researchandmarkets.com — Fri, 18 Sep 2009 14:50:19 GMT

The field of C-nanoparticles toxicity is, at present, fragmented and contradictory, oscillating between enthusiastic raptures and bitter disappointments This important book presents an overall, unitary view of the carbon nanoparticle world, in which both the positive and negative aspects of these...

Dendrimer-Based Nanomedicine

press@researchandmarkets.com — Fri, 18 Sep 2009 14:37:22 GMT

In recent decades, dendrimers — free-shaped synthetic macromolecules — have garnered a great deal of scientific interest due to their unique molecular nanostructure Used in a variety of scientific applications, the use of dendrimers is now widely regarded as a safer, more precise, and more effective...

Nanobiotechnology And Nanobiosciences

press@researchandmarkets.com — Fri, 18 Sep 2009 13:54:58 GMT

Nanobiotechnology is capable of yielding a scientific and industrial revolution, as envisioned by the numerous programs on nanotechnology launched over the last decade by councils and governments worldwide, beginning in late 1995 by the Science and Technology Council in Italy, by President Clinton...

Nanopathology: The Health Impact of Nanoparticles

press@researchandmarkets.com — Fri, 18 Sep 2009 13:53:38 GMT

Enormous funds are currently being invested in nanotechnology, yet very little is known about how its products and by-products can interfere with organisms, both end-users and people involved in their manufacture Similar scenarios are already widely known in the history of science, such as the...

Competitor Analysis: EGF-R Agonists and Antagonists

press@researchandmarkets.com — Thu, 17 Sep 2009 13:31:03 GMT

The present Competitive Intelligence Report about EGF-R agonists and antagonists provides a competitor evaluation in the field of epidermal growth factor receptor (EGF-R; ErbB1) targeting molecules for wound healing or treatment of cancer as of September 2009 Purchase of the downloadable pdf report...

Basic Statistics: A Primer for the Biomedical Sciences, 4th Edition

press@researchandmarkets.com — Thu, 17 Sep 2009 11:07:53 GMT

New Edition of a Classic Guide to Statistical Applications in the Biomedical Sciences In the last decade, there have been significant changes in the way statistics is incorporated into biostatistical, medical, and public health research Addressing the need for a modernized treatment of these...

Nanotoxicity: From In Vivo and In Vitro Models to Health Risks

press@researchandmarkets.com — Thu, 17 Sep 2009 08:40:25 GMT

Nanomaterials substances smaller than 100 nanometers in size have been added in recent years to an increasing numbers of consumer products used in day-to-day life; in food packaging, medical devices, pharmaceuticals, cosmetics, odor-resistant textiles and household appliances The extensive...

Peptide and Protein Design for Biopharmaceutical Applications

press@researchandmarkets.com — Tue, 15 Sep 2009 11:00:53 GMT

Peptides serve as effective drugs in the clinic today However the inherent drawbacks of peptide structures can limit their efficacy as drugs To overcome this researchers are developing new methods to create ‘tailor-made’ peptides and proteins with improved pharmacological properties Design of...

Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)

press@researchandmarkets.com — Fri, 11 Sep 2009 14:57:10 GMT

The global market for neurostimulation products is expected to be worth $3 6 billion in 2009, growing at a CAGR of 22 7%, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry Neurostimulation is used for the treatment of...

Advances in Biomedical and Biomimetic Materials: Ceramic Transactions, Volume 206

press@researchandmarkets.com — Fri, 11 Sep 2009 13:46:32 GMT

This book contains the proceedings of the “Advances in Biomedical and Biomimetic Materials” symposium, held in 2008 in Pittsburgh, Pennsylvania Presentations were given on recent developments in biomedical and biomimetic materials, including scaffolds for tissue engineering; bioceramics; biomimetic...

Biomedical Materials - Issue 8, 2009

press@researchandmarkets.com — Thu, 10 Sep 2009 10:34:38 GMT

A monthly news alert which addresses all the latest developments in ceramics, composites, metals, polymers and textiles for biomedical use including advances in materials, product launches and trials, industry news, international regulatory issues and an alerting service to the latest research...

TecTrends Reporter: Biotechnology Key Recent Media Coverage, Issue 09Q2

press@researchandmarkets.com — Wed, 09 Sep 2009 09:28:32 GMT

One of the most important and rapidly evolving industries of the 21st century, biotechnology promises huge improvements in such critical areas as health care and environmental conservation This TecTrends Reporter tracks developments across a wide range of biotech industry sectors including genetics...

France Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:32:44 GMT

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics and economic indicators. It analyzes the critical success factors in the industry - how the industry has evolved and how competitive dynamics have impacted market behavior.

Sectional Highlights:

- Structure of the industry, market size, and growth rates have been analyzed
- Value chain analysis categorizes the value-adding activities to develop low-cost differentiation strategies
- Trend analysis detects historical patterns that could help in forecasting future demand periods
- Critical issues are reviewed that may become a threat to the industry
- PEST analysis uses a framework of external factors for macro-environmental scanning of the industry to help in taking advantage of opportunities and making contingency plans for threats
- Competitive positioning of the industry leaders has been evaluated in terms of sales, profitability, stock trend and other performance indicators

Key Benefits:

- Provides input for strategic business planning
- Targets business opportunities & risks
- Exploits competitive intelligence

Target Audience:

- Investment Managers
- Venture Capitalists
- Management Consultants
- Research Companies
- Other Industry Professionals

German Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:32:33 GMT

Australian Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:32:23 GMT

Japanese Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:32:15 GMT

Chinese Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:32:07 GMT

Indian Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:31:57 GMT

UK Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:31:42 GMT

US Biotechnology Sector: Sector Report

press@researchandmarkets.com — Tue, 08 Sep 2009 13:31:07 GMT

The Italian Coagulation Market, 2009-2018

press@researchandmarkets.com — Mon, 07 Sep 2009 15:40:29 GMT

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice...

Southeast Asia Oleochemicals Market

press@researchandmarkets.com — Thu, 03 Sep 2009 13:30:01 GMT

Slides 1 to 120 provide the current and future trends of the oleochemicals market for Southeast Asia from 2008 to 2015 In this study, the base year is 2008, and the forecast period is from 2009 to 2015 The study comprises of oleochemicals such as fatty acids, fatty alcohol and refined glycerin The...

Biotech Exit Strategies: Delivering Value to Investors in a Challenging Funding Market

press@researchandmarkets.com — Mon, 24 Aug 2009 10:14:18 GMT

Biotechnology ventures involve costly research and development and a 10-20 year delay in generating product revenues The high risk nature of early stage biotech research is primarily funded through venture capital, with high risks resulting in potentially high rewards While the biotech venture model...

Biofuels Market in China 2009

press@researchandmarkets.com — Mon, 17 Aug 2009 14:54:46 GMT

The rapidly developing Chinese biofuel market has been the hotspot in the past few years since the renewable biofuel is of great importance to relieve energy shortage in the future To figure out the current situation and prospect of biofuel in China, this report widely covers information about...

CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology

press@researchandmarkets.com — Fri, 07 Aug 2009 15:14:23 GMT

This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009 It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000...

Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics

press@researchandmarkets.com — Thu, 06 Aug 2009 11:01:38 GMT

Forward-thinkers in the biopharmaceutical industry recognize employers as true payers of healthcare, ready to assume a more active role in healthcare decision making As a result, many companies are seeking ways to serve this underappreciated space in an alternative, complementary approach to the...

Medical Affairs Resources, Structures and Trends

press@researchandmarkets.com — Thu, 06 Aug 2009 10:54:51 GMT

Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions, including publications, KOL programs, grants, and medical education (CME) that have been impacted in recent years by a call for increased...

Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts

press@researchandmarkets.com — Thu, 06 Aug 2009 10:47:33 GMT

Health Outcomes data has become increasingly important to the success of biotechnology and pharmaceutical companies This study aims to discover and collect best practices in how companies use and review the use of Health Outcomes data in promotional/commercial settings There is a focus upon...

Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009

press@researchandmarkets.com — Wed, 05 Aug 2009 11:33:18 GMT

Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009: Development forecasts for biotechnology sector for 2009-2011 Biotechnological innovations in the pharmaceutical industry in Poland 2009 provides a comprehensive overview of the biotechnology market in Poland Covering major...

Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009

press@researchandmarkets.com — Wed, 05 Aug 2009 11:33:12 GMT

Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition

press@researchandmarkets.com — Wed, 22 Jul 2009 15:24:02 GMT

The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies This report provides details of the latest manufacturing...